Paxil
Get
a free Paxil case evaluation<<<<<<<
FDA Warns Of Risks With The Use Of Paxil – Birth
Defects And Suicide
The side effects of Paxil have caused serious medical and psychological
complications in some patients and have most recently been linked
to birth defects and suicide. Please CLICK HERE for a free case
evaluation.
Birth Defects
In December 2005, the U.S. Food and Drug Administration (FDA)
issued a Safety Alert
advising healthcare professionals that exposure to Paxil (and
the generic Paroxetine) in the first trimester of pregnancy may
increase the risk for congenital birth defects especially cardiac
birth defects. Most of the cardiac defects involved an underdeveloped
wall between the left and right side of the heart. At the FDA’s
request, Glaxo Smith Kline (the manufacturer of Paxil) has changed
the pregnancy precaution of Paxil from C to D and updated the
label to read that Paxil should only be used during pregnancy
if the potential benefits outweigh the risk to the fetus.
The New England Journal of Medicine, published February 9, 2006,
showed that babies born to mothers who took selective serotonin
reuptake inhibitors (SSRI), antidepressants like Paxil, after
the 20th week of pregnancy were 6 times more likely to have persistent
pulmonary hypertension (PPHN) than those born to mothers who
did not take an SSRI during pregnancy. In July 2006, the FDA
issued a Safety Alert advising that pregnant women who are taking
Paxil and other SSRIs could give birth to a baby with PPHN. Babies
with PPHN have abnormal blood flow through the heart and lungs
and do not get enough oxygen. This can cause babies to be very
sick and die. The FDA updated information for all SSRIs with
these findings. Some commonly used SSRIs are Celexa, Lexapro,
Fluvoxamine, Paxil, Prozac and Zoloft.
Suicide
Some experts believe that the use of Paxil and other SSRIs can
increase the risk of suicidal thoughts and behavior in children,
adolescents and young adults. In 2004, the FDA called for a black
box warning to be displayed on Paxil and other antidepressants,
warning of an increase in suicide and violence in children and
adolescents. In December 2006, an FDA federal panel called for
the black box warning to extend to young adults. Glaxo Smith
Kline, the makers of Paxil, concealed information from four studies
that concluded the drug was ineffective in treating depression
in young people and potentially increased the risk of suicidal
thoughts.
Your Rights
Because the makers of Paxil have been accused of failing to
warn the public of some of the dangers of taking Paxil, our attorneys
are pursuing claims on behalf of clients who have been injured
from the use of Paxil. A lawyer familiar with new developments
in the investigation of Paxil may be able to help you make important
personal and legal decisions and if needed file a Paxil lawsuit.
Please CLICK HERE for a free consultation.
Breaking News:
FDA Advisory of Risk of Birth Defects with Paxil
http://www.fda.gov/bbs/topics/NEWS/2005/NEW01270.html
last updated 3/19/2007
|